Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Biceltis 440Mg Injection (Trastuzumab)

Manufacturer: Emcure Pharmaceuticals Ltd

Medicine composition: Trastuzumab

Biceltis 440Mg Injection is used in the treatment of metastatic breast cancer. It works on tumors known to overexpress the protein HER2/neu. It also treats gastric cancer.

This drug is mostly administered through IV. The initial dose may be given for about 90 minutes. If the patient’s body reacts positively to Biceltis 440Mg Injection, the following doses may be given for about 30 minutes. The dosage of Biceltis 440Mg Injection that is administered generally depends on the severity of the cancer, health of the patient, body weight and height and other health problems that the patient may already have.

ask for Quote : info@mbapharmaceuticals.com

Specialty: